ArticleActa pharmaceutica Sinica. B2024

A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy.

Xiaozhi Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.